CY1114456T1 - VIRUS POLYMERASE INHIBITIONS - Google Patents
VIRUS POLYMERASE INHIBITIONSInfo
- Publication number
- CY1114456T1 CY1114456T1 CY20131100861T CY131100861T CY1114456T1 CY 1114456 T1 CY1114456 T1 CY 1114456T1 CY 20131100861 T CY20131100861 T CY 20131100861T CY 131100861 T CY131100861 T CY 131100861T CY 1114456 T1 CY1114456 T1 CY 1114456T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitions
- virus polymerase
- polymerase
- compound
- viral
- Prior art date
Links
Abstract
Ένα εναντιομερές, διαστερεομερές ή ταυτομερές μίας ενώσεως, που αναπαρίσταται από τον τύπο (Ι): όπου είτε το Α είτε το Β είναι άζωτο και το άλλο Β ή Α είναι C και οι ρίζες R1, R2, R3, R4, R5, R6, R7, R8, R9 και R10 είναι όπως ορίζεται στο παρόν, ή ένα άλας ή ένας εστέρας αυτής ως αναστολείς ιικής πολυμεράσης. Η ένωση χρησιμοποιείται ως αναστολέας RΝΑ πολυμερασών εξαρτώμενων από RΝΑ, συγκεκριμένα εκείνων των ιικών πολυμερασών εντός της οικογένειας Flaviviridae, πιο συγκεκριμένα ΗCV πολυμεράσης.An enantiomer, diastereomer or tautomer of a compound, represented by formula (I): wherein either A or B is nitrogen and the other B or A is C and the radicals R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined herein, or a salt or ester thereof as viral polymerase inhibitors. The compound is used as an RNA-dependent RNA polymerase inhibitor, in particular those of the viral polymerases within the Flaviviridae family, in particular HCV polymerase.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54621304A | 2004-02-20 | 2004-02-20 | |
| EP05714457.8A EP1718608B1 (en) | 2004-02-20 | 2005-02-18 | Viral polymerase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114456T1 true CY1114456T1 (en) | 2016-10-05 |
Family
ID=58448769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100861T CY1114456T1 (en) | 2004-02-20 | 2013-10-04 | VIRUS POLYMERASE INHIBITIONS |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1114456T1 (en) |
-
2013
- 2013-10-04 CY CY20131100861T patent/CY1114456T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20064004L (en) | Viral polymerase inhibitors | |
| ECSP077171A (en) | VIRAL POLYMERASE INHIBITORS | |
| DK1654261T3 (en) | Hepatitis C inhibitor compounds | |
| NO20082934L (en) | Antiviral nucleotides | |
| DE602004017126D1 (en) | ACYLSULFONAMIDE COMPOUNDS AS INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE | |
| CY1112108T1 (en) | DISEASES OF USVITIS C | |
| TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
| NO20062185L (en) | Hepatitis C virus inhibitors | |
| NZ526703A (en) | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | |
| ATE542826T1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| DK1569929T3 (en) | Compounds and Methods for Treating or Preventing Flavivirus Infections | |
| ATE420078T1 (en) | PYRIMIDINONES AS VIRAL POLYMERASE INHIBITORS | |
| EA200900156A1 (en) | Pyridazine compound (VARIANTS), METHOD FOR ITS PREPARATION (VARIANTS), METHOD FOR TREATMENT OR PREVENTION OF VIRAL INFECTION WITH HEPATITIS C USING IT, compositions and medicaments based on its | |
| MX2012006513A (en) | Heterocyclic antiviral compounds. | |
| ATE498398T1 (en) | CYCLOALKYL HETEROCYCLES FOR THE TREATMENT OF HEPATITIS C VIRUS | |
| CY1114456T1 (en) | VIRUS POLYMERASE INHIBITIONS | |
| ATE491706T1 (en) | HETEROCYCLIC ANTIVIRAL COMPOUNDS | |
| UY28168A1 (en) | VIRAL POLYMERASE INHIBITORS |